– Minneapolis, MN Cardiac Drug Toxicity and Discovery Screening Reaches New Relevance with Launch of microHeart® at SLAS2017 StemoniX® to release new data demonstrating how microHeart aligns cardiac cells into physiologically relevant structures, representing a breakthrough in powerful human iPSC screening platforms. Minneapolis-based StemoniX, Inc. will present research demonstrating superiority of their microHeart® microplates over […]